---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-023520"
form_type: "8-K"
ticker: "LNSR"
cik: "0001320350"
company_name: "LENSAR, Inc."
filed_at: "2022-11-09T23:59:59+00:00"
generated_at: "2026-06-22T00:48:17.650331+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# LENSAR Q3 2022 revenue down 6% to $7.7M; net loss narrows to $4.0M; launches ALLY system

## Summary
- Revenue $7.7M, down 6% YoY; U.S. procedure volume up 9%, offset by South Korean reimbursement challenges.
- Net loss of $4.0M (-$0.39 per share) improved from $6.2M loss (-$0.65) in Q3 2021; Adjusted EBITDA -$1.6M.
- Launched ALLY Adaptive Cataract Treatment System in the U.S. in August 2022; first installations with positive surgeon feedback.
- R&D expenses dropped 50% to $1.6M as ALLY development costs capitalized after June 2022 clearance.
- Approximately 88% of revenue from recurring sources; worldwide procedure volume 28,453 in Q3.

## SEC filing metadata
- accession: 0000950170-22-023520
- form_type: 8-K
- ticker: LNSR
- cik: 0001320350
- company_name: LENSAR, Inc.
- filed_at: 2022-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320350/000095017022023520/0000950170-22-023520-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320350/000095017022023520/lnsr-20221109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-023520
- JSON: https://secwatch.observer/filing/0000950170-22-023520.json
- Plain text: https://secwatch.observer/filing/0000950170-22-023520.txt

## Key facts
- Earnings Releases
  LENSAR, Inc. reported the quarter ended September 30, 2022 results: revenue $7.7 million, net income $4.0 million, or ($0.39) per share.
  - Period: the quarter ended September 30, 2022
  - Revenue: $7.7 million
  - Net income: $4.0 million, or ($0.39) per share
  - Result: reported results
  source text: with 2.5 - 3 minutes when using prior generation and competitive technologies.” Third Quarter 2022 Financial Results Total revenue for the quarter ended September 30, 2022 was $7.7 million, a decrease of $0.5 million, or 6%, compared to total revenue of $8.3 million for the quarter ended September 30, 2021. The decrease in third quarter 2022 revenue was associated
  evidence_url: https://www.sec.gov/Archives/edgar/data/1320350/000095017022023520/0000950170-22-023520-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.